akash.verma@cenmed.com
(732) 447-1115-
-
-
-
V597157-500mgVal-Cit is a cleavable ADC linker. The Val-Cit can be specifically cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell. -
V597157-250mgVal-Cit is a cleavable ADC linker. The Val-Cit can be specifically cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell. -
V597157-1gVal-Cit is a cleavable ADC linker. The Val-Cit can be specifically cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell. -
V596242-5mgVal-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a maleimidocaproyl (MC) spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a -
V596242-25mgVal-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a maleimidocaproyl (MC) spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a -
S658793-5mgSuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB.Appearance:SolidIC50&: Target:AuristatinIn Vitro:ADCs are -
S658793-50mgSuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB.Appearance:SolidIC50&: Target:AuristatinIn Vitro:ADCs are -
S658793-10mgSuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB.Appearance:SolidIC50&: Target:AuristatinIn Vitro:ADCs are -
S658793-100mgSuO-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB.Appearance:SolidIC50&: Target:AuristatinIn Vitro:ADCs are
